Groowe Groowe / Newsroom / ARTV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ARTV News

Artiva Biotherapeutics, Inc. Common Stock

Form 8-K

sec.gov
ARTV

Artiva Biotherapeutics Provides Update on Planned AlloNKĀ® Data Disclosures and Development Milestones for the Remainder of 2026

globenewswire.com
ARTV

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September

globenewswire.com
ARTV

Form 8-K

sec.gov
ARTV

Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

globenewswire.com
ARTV

Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

globenewswire.com
ARTV

Form 8-K

sec.gov
ARTV

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
ARTV

U.S. Hemostatic Sealants in Arterial Surgery Market Size, Share & Trends Analysis Report by Product, End Use, Application, Disease Indication, and Segment Forecasts, 2026-2033 Published; Maps U.S. TAM Trends

globenewswire.com
ARTV BDX TFX

Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

globenewswire.com
ARTV